Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity

Journal of Virology

Volumn 80, Issue 3, 2006, Pages 1280-1289

  Thorp, Edward B ^a,b   Boscarino, Joseph A ^a   Logan, Hillary L ^a   Goletz, Jeffrey T ^a   Gallagher, Thomas M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMOPALMITIC ACID; ACYLTRANSFERASE; ACYLTRANSFERASE INHIBITOR; CYSTEINE; MEMBRANE PROTEIN; PALMITOYL ACYLTRANSFERASE; PHENYLALANINE; SERINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS SPIKE PROTEIN;

ACYLATION; ALPHA VIRUS; ANIMAL CELL; ARTICLE; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; CORONAVIRUS; DOSE RESPONSE; EXOCYTOSIS; HUMAN; HUMAN CELL; MEMBRANE FUSION; MOLECULAR GENETICS; MOUSE; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RHABDOVIRUS; VIRION; VIRUS ASSEMBLY; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS MUTATION;

ACYLATION; ACYLTRANSFERASES; ANIMALS; CELL LINE; CRICETINAE; ENZYME INHIBITORS; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MURINE HEPATITIS VIRUS; PALMITATES; PALMITIC ACIDS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINATION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRULENCE; VIRUS ASSEMBLY;

ALPHAVIRUS; ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; RHABDOVIRIDAE;

EID: 31144479683     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.3.1280-1289.2006     Document Type: Article

References (56)

1. Arni, S., S. A. Keilbaugh, A. G. Ostermeyer, and D. A. Brown. 1998. Association of GAP-43 with detergent-resistant membranes requires two palmitoylated cysteine residues. J. Biol. Chem. 273:28478-28485.
2. Bos, E. C. W., L. Heijnen, W. Luytjes, and W. J. M. Spaan. 1995. Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion, Virology 214:453-463.
3. Bosch, B. J., C. A. de Haan, S. L. Smits, and P. J. Rottier. 2005. Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements. Virology 334:306-318.
4. Bosch, B. J., R. van der Zee, C. A. de Haan, and P. J. Rottier. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77:8801-8811.
5. Brown, D. 2002. Structure and function of membrane rafts. Int. J. Med. Microbiol. 291:433-437.
6. Cavanagh, D. 1995. The coronavirus surface glycoprotein, p. 73-115. In S. G. Siddell, ed., The Coronaviridae. Plenum Press, New York, N.Y.
7. Chang, K. W., Y. Sheng, and J. L. Gombold. 2000. Coronavirus-induced membrane fusion requires the cysteine-rich domain in the spike protein. Virology 269:212-224.
8. Danieli, T., S. L. Pelletier, Y. I. Henis, and J. M. White. 1996. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133:559-569.
9. Davies, H. A., and M. R. Macnaughton. 1979. Comparison of the morphology of three coronaviruses. Arch. Virol. 59:25-33.
10. de Haan, C. A., K. Stadler, G. J. Godeke, B. J. Bosch, and P. J. Rottier. 2004. Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J. Virol. 78:6048-6054.
11. de Haan, C. A. M., M. Smeets, F. Vernooij, H. Vennema, and P. J. M. Rottier. 1999. Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J. Virol. 73:7441-7452.
12. Dunphy, J. T., W. K. Greentree, C. L. Manahan, and M. E. Linder. 1996. G-protein palmitoyltransferase activity is enriched in plasma membranes. J. Biol. Chem. 271:7154-7159.
13. Fuerst, T. R., P. L. Earl, and B. Moss. 1987. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7:2538-2544.
14. Gallagher, T. M. 1997. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 71:3129-3137.
15. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
16. Harder, T., P. Scheiffele, P. Verkade, and K. Simons. 1998. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141:929-942.
17. Jardetzky, T. S., and R. A. Lamb. 2004. Virology: a class act. Nature 427:307-308.
18. Jin, H., K. Subbarao, S. Bagai, G. P. Leser, B. R. Murphy, and R. A. Lamb. 1996. Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. J. Virol. 70:1406-1414.
19. Krijnske-Locker, J., M. Ericsson, P. J. Rottier, and G. Griffiths. 1994. Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J. Cell Biol. 124:55-70.
20. Krueger, D. K., S. M. Kelly, D. N. Lewicki, R. Ruffolo, and T. M. Gallagher. 2001. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion. J. Virol. 75:2792-2802.
21. Kuo, L., G. J. Godeke, M. J. Raamsman, P. S. Masters, and P. J. Rottier. 2000. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J. Virol. 74:1396-1406.
22. Makino, S., F. Taguchi, and K. Fujiwara. 1984. Defective interfering particles of mouse hepatitis virus. Virology 133:9-17.
23. Masters, P. S., and P. J. Rottier. 2005. Coronavirus reverse genetics by targeted RNA recombination. Curr. Top. Microbiol. Immunol. 287:133-159.
24. McLaughlin, R. E., and J. B. Denny. 1999. Palmitoylation of GAP-43 by the ER-Golgi intermediate compartment and Golgi apparatus. Biochim. Biophys. Acta 1451:82-92.
25. Melkonian, K. A., A. G. Ostermeyer, J. Z. Chen, M. G. Roth, and D. A. Brown. 1999. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts: many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274:3910-3917.
26. Ontiveros, E., T. S. Kim, T. M. Gallagher, and S. Perlman. 2003. Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein. J. Virol. 77:10260-10269.
27. Ontiveros, E., L. Kuo, P. S. Masters, and S. Perlman. 2001. Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology 289:230-238.
28. Opstelten, D.-J. E., M. J. B. Raamsman, K. Wolfs, M. C. Horzinek, and P. J. M. Rottier. 1995. Envelope glycoprotein interactions in coronavirus assembly. J. Cell Biol. 131:339-349.
29. Perlman, S. 1998. Pathogenesis of coronavirus-induced infections. Adv. Exp. Med. Biol. 440:503-513.
30. Phillips, J. J., M. M. Chua, E. Lavi, and S. R. Weiss. 1999. Pathogenesis of chimeric MHV4/MHVA59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J. Virol. 73:7752-7760.
31. Pralle, A., P. Keller, E. L. Florin, K. Simons, and J. K. Horber. 2000. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell Biol. 148:997-1008.
32. Rao, P. V., and T. M. Gallagher. 1998. Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections. J. Virol. 72:3278-3288.
33. Resh, M. D. 2004. Membrane targeting of lipid modified signal transduction proteins. Subcell. Biochem. 37:217-232.
34. Rocks, O., A. Peyker, M. Kahms, P. J. Verveer, C. Koerner, M. Lumbierres, J. Kuhlmann, H. Waldmann, A. Wittinghofer, and P. I. Bastiaens. 2005. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307:1746-1752.
35. Rousso, I., M. B. Mixon, B. K. Chen, and P. S. Kim. 2000. Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proc. Natl. Acad. Sci. USA 97:13523-13525.
36. Sawicki, S. G. 1987. Characterization of a small plaque mutant of the A59 strain of mouse hepatitis virus defective in cell fusion. Adv. Exp. Med. Biol. 218:169-174.
37. Scheiffele, P., A. Rietveld, T. Wilk, and K. Simons. 1999. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 274:2038-2044.
38. Simmons, G., J. D. Reeves, A. J. Rennekamp, S. M. Amberg, A. J. Piefer, and P. Bates. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA 101:4240-4245.
39. Smit, J. M., R. Bittman, and J. Wilschut. 2001. Deacylation of the transmembrane domains of Sindbis virus envelope glycoproteins E1 and E2 does not affect low-pH-induced viral membrane fusion activity. FEBS Lett. 498:57-61.
40. Smotrys, J. E., and M. E. Linder. 2004. Palmitoylation of intracellular signaling proteins: regulation and function. Annu. Rev. Biochem. 73:559-587.
41. Sturman, L. S., C. S. Ricard, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:904-911.
42. Sturman, L. S., and K. K. Takemoto. 1972. Enhanced growth of a murine coronavirus in transformed mouse cells. Infect. Immun. 6:501-507.
43. Takeda, M., G. P. Leser, C. J. Russell, and R. A. Lamb. 2003. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc. Natl. Acad. Sci. USA 100:14610-14617.
44. Thorp, E. B., and T. M. Gallagher. 2004. Requirements for CEACAMs and cholesterol during murine coronavirus cell entry. J. Virol. 78:2682-2692.
45. Tooze, J., S. Tooze, and G. Warren. 1984. Replication of coronavirus MHV-A59 in sac- cells: determination of the first site of budding of progeny virions. Eur. J. Cell Biol. 33:281-293.
46. van Berlo, M. F., W. J. van den Brink, M. C. Horzinek, and B. A. M. van der Zeijst. 1987. Fatty acid acylation of viral proteins in murine hepatitis virus-infected cells. Arch. Virol. 95:123-130.
47. Varner, A. S., M. L. De Vos, S. P. Creaser, B. R. Peterson, and C. D. Smith. 2002. A fluorescence-based high performance liquid chromatographic method for the characterization of palmitoyl acyl transferase activity. Anal. Biochem. 308:160-167.
48. Veil, M., L. E. Dietrich, and C. Ungermann. 2003. Biochemical characterization of the vacuolar palmitoyl acyltransferase. FEBS Lett. 540:101-105.
49. Vennema, H., G. J. Godeke, J. W. Rossen, W. F. Voorhout, M. C. Horzinek, D. J. Opstelten, and P. J. Rottier. 1996. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 15:2020-2028.
50. Wagner, R., A. Herwig, N. Azzouz, and H. D. Klenk. 2005. Acylation-mediated membrane anchoring of avian influenza virus hemagglutinin is essential for fusion pore formation and virus infectivity. J. Virol. 79:6449-6458.
51. Webb, V., L. Hermida-Matsumoto, and M. D. Resh. 2000. Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J. Biol. Chem. 275:261-270.
52. Weiner, L. P. 1973. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Arch. Neurol. 28:298-303.
53. Whitt, M. A., and J. K. Rose. 1991. Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions. Virology 185:875-878.
54. Ye, R., C. Montalto-Morrison, and P. S. Masters. 2004. Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain. J. Virol. 78:9904-9917.
55. Zhang, S. X., V. Han, and G. W. Blissard. 2003. Palmitoylation of the Autographa califormica multicapsid nucleopolyhedrovirus envelope glycoprotein GP64: mapping, functional studies, and lipid rafts. J. Virol. 77:6265-6273.
56. Zurcher, T., G. Luo, and P. Palese. 1994. Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation. J. Virol. 68:5748-5754.